MD-1100 Acetate

DRUG2 trials

Sponsors

Ironwood Pharmaceuticals, Inc.

Conditions

ConstipationIrritable Bowel Syndrome

Phase 2

Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS

CompletedNCT00258193

Ironwood Pharmaceuticals, Inc.Irritable Bowel Syndrome

Start: 2006-01-31End: 2006-09-30Target: 36Updated: 2006-10-20

Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation

CompletedNCT00306748

Ironwood Pharmaceuticals, Inc.Constipation

Start: 2006-03-31End: 2006-08-31Target: 40Updated: 2009-03-24